Literature DB >> 570022

Alterations in plasma norepinephrine concentration during surgical resection of pheochromocytoma.

J M Feldman, J A Blalock, L Fagraeus, J N Miller, R E Farrell, S A Wells.   

Abstract

Using a sensitive and specific radioenzymatic assay, the plasma norepinephrine (NE) concentration was measured in seven patients with pheochromocytoma, one patient with bilateral adrenal medullary hyperplasia, one patient with a retroperitoneal paraganglioma, and two patients undergoing bilateral adrenalectomies for palliation of metastatic breast carcinoma. Surgical manipulation of the pheochromocytomas resulted in striking increases in plasma NE concentration with concomitant increases in blood pressure. There were either small changes or no changes in the patients' plasma NE and blood pressure during resection of the normal adrenal glands, the adrenal glands with medullary hyperplasia, or the retroperitoneal paraganglioma. Plasma dopamine-beta-hydroxylase (DBH) was measured in one patient with pheochromocytomas and the patient with medullary hyperplasia. There was no change in plasma DBH in either patient, supporting the concept that exocytosis is not the primary mechanism for catecholamine secretion from pheochromocytomas. It was also noted that enflurane is an excellent general anesthetic for the resection of pheochromocytomas, and that sodium nitroprusside (rather than phentolamine) may be the agent of choice for the management of the hypertensive episodes that occur during surgical manipulation of pheochromocytomas.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 570022      PMCID: PMC1396999          DOI: 10.1097/00000658-197812000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

2.  HALOTHANE ANESTHESIA AND CATECHOLAMINE LEVELS IN A PATIENT WITH PHEOCHROMOCYTOMA.

Authors:  B E ETSTEN; S SHIMOSATO
Journal:  Anesthesiology       Date:  1965 Sep-Oct       Impact factor: 7.892

3.  Determination by thin-layer chromatography of urinary homovanillic acid in normal and disease states.

Authors:  I SANKOFF; T L SOURKES
Journal:  Can J Biochem Physiol       Date:  1963-06

4.  Phentolamine-resistant pheochromocytoma treated with sodium nitroprusside.

Authors:  D S NOUROK; G GWINUP; G J HAMWI
Journal:  JAMA       Date:  1963-03-09       Impact factor: 56.272

5.  A simple analysis for normetanephrine and metanephrine in urine.

Authors:  J J PISANO
Journal:  Clin Chim Acta       Date:  1960-05       Impact factor: 3.786

6.  Fluorimetric estimation of noradrenaline and adrenaline in urine.

Authors:  U S VON EULER; I FLODING
Journal:  Acta Physiol Scand Suppl       Date:  1955

7.  Determination of 3-methoxy-4-hydroxymandelic acid in urine.

Authors:  J J PISANO; J R CROUT; D ABRAHAM
Journal:  Clin Chim Acta       Date:  1962-03       Impact factor: 3.786

8.  Pheochromocytoma. Anesthetic management during surgical treatment.

Authors:  V APGAR; E M PAPPER
Journal:  AMA Arch Surg       Date:  1951-05

9.  Sodium nitroprusside and lidocaine in the anaesthetic management of pheochromocytoma.

Authors:  M El-Naggar; E Suerte; E Rosenthal
Journal:  Can Anaesth Soc J       Date:  1977-05

10.  Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland.

Authors:  S A Wells; S B Baylin; W M Linehan; R E Farrell; E B Cox; C W Cooper
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

View more
  12 in total

Review 1.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

2.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

3.  Adenosine: a new antihypertensive agent during pheochromocytoma removal.

Authors:  S Gröndal; L Bindslev; A Sollevi; B Hamberger
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

4.  Secretory pattern and blood pressure in pheochromocytoma.

Authors:  S Gröndal; B Hamberger; M Telenius-Berg
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

5.  A paroxysmally secreting phaeochromocytoma: biochemical and clinical aspects.

Authors:  H Hörtnagl; D Magometschnigg; H Lochs; W Druml
Journal:  Klin Wochenschr       Date:  1983-06-15

6.  Laparoscopic curative resection of pheochromocytomas.

Authors:  Kent W Kercher; Yuri W Novitsky; Adrian Park; Brent D Matthews; Demetrius E M Litwin; B Todd Heniford
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

7.  PTH Spikes During Surgical Treatment for Secondary and Tertiary Hyperparathyroidism: A Prospective Observational Study.

Authors:  Andre Albuquerque Silveira; Marilia D'Elboux Guimaraes Brescia; Climerio Pereira do Nascimento; Felipe Ferraz Magnabosco; Sergio Samir Arap; Fabio Luiz de Menezes Montenegro
Journal:  World J Surg       Date:  2022-03-09       Impact factor: 3.282

8.  Safety and feasibility of laparoscopic resection for large (≥ 6 CM) pheochromocytomas without suspected malignancy.

Authors:  Yvette M Carter; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Endocr Pract       Date:  2012 Sep-Oct       Impact factor: 3.443

9.  Laparoscopic adrenalectomy for pheochromocytoma: take the vein last?

Authors:  Melina C Vassiliou; William S Laycock
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

10.  Anaesthetic management with morphine in phaeochromocytoma.

Authors:  M Hamaji; N Oka; C Tashiro; T Seki; M Miyata; Y Kawashima
Journal:  Can Anaesth Soc J       Date:  1984-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.